St. Jude Jan 20, 2022 Polygenic Scoring Shows Promise in Guiding Induction Chemo in Pediatric AML in Early Research Premium Jun 11, 2021 Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Dec 8, 2020 Genetic Loci Influence Risk of Cardiomyopathy in Pediatric Cancer Survivors of African Ancestry Jul 13, 2020 Discovery of Inherited Mutation Sheds Light on Increased Cancer Risk in Brazilians Premium Jun 5, 2020 Secondary Tumor Risk in Pediatric Cancer Survivors Linked to Germline Variants, Treatment Type Mar 9, 2020 Integrated Genomic Analysis Highlights Potential Strategy for Overcoming Some ALL Resistance Aug 7, 2019 Pediatric Cancer Researchers, Clinicians Look to Enhance Molecular Data Collection, Distribution Jul 23, 2019 Pediatric Oncologists Employing Variety of Sequencing Strategies for Treatment, Research Premium Jun 25, 2019 Pediatric Cancer Big Data Initiatives Could Help Set Best Practices for Sequencing, Data Sharing Premium Jun 18, 2019 Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms Premium May 16, 2019 NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy Premium Mar 4, 2019 Spitzoid Melanoma Sequencing Reveals MEK Inhibitor Target Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors
